Εμφανίζονται 1 - 20 Αποτελέσματα από 72 για την αναζήτηση '"комбинированные операции"', χρόνος αναζήτησης: 0,62δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Συγγραφείς: Ceнютович , Р.

    Πηγή: Clinical anatomy and operative surgery; Vol. 7 No. 1 (2008); 8-11
    Клиническая анатомия и оперативная хирургия; Том 7 № 1 (2008); 8-11
    Клінічна анатомія та оперативна хірургія; Том 7 № 1 (2008); 8-11

    Περιγραφή αρχείου: application/pdf

    Σύνδεσμος πρόσβασης: http://kaos.bsmu.edu.ua/article/view/232517

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
    Academic Journal

    Πηγή: Acta Biomedica Scientifica; Том 3, № 2 (2018); 44-49 ; 2587-9596 ; 2541-9420

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.actabiomedica.ru/jour/article/view/558/559; Давыдов М.М., Мачаладзе З.О. Саркомы торако -абдоминальной локализации (современная стратегия хирургического лечения) // Вестник РОНЦ им. Н.Н. Блохина. - 2015. - № 1. - С. 3-14; Поляков В.Г., Рябов А.Б., Ким Э.Ф., Лебедев В.И., Казанцев А.П., Керимов П.А., Рубанский М.А., Нечушкина И.В., Капкова О.А., Рубанская М.А., Рыбакова Д.В. Хирургический метод при опухолях торакоабдоминальной локализации у детей: современное состояние проблемы и опыт клиники // Онкопедиатрия. 2014. - № 1. - С. 13-19; Стилиди И.С., Губина Г.И., Неред С.Н., Клименков А.А., Сельчук В.Ю., Тюрин И.Е., Назлиев П.Б. Непосредственные результаты хирургического лечения неорганных забрюшинных опухолей // Российский онкологический журнал. - 2007. - № 1. - С. 25-28; Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, Laplanche A. (2009). Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol, 27 (1), 31-37. doi:10.1200/JCO.2008.18.0802; Clavien PA, Sanabria JR, Strasberg SM. (1992). Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery, 111 (5), 518-526.; Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. (2009). The Clavien - Dindo classification of surgical complications: five-year experience. Ann Surg, 250 (2), 187-196. doi:10.1097/SLA.0b013e3181b13ca2; Dindo D, Demartines N, Clavien PA. (2004). Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 240 (2), 205-213; Gronchi A, Bonvalot S, Le Cesne A, Casali PG. (2009). Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma. J Clin Oncol, 27 (12), 2106-2107; Gronchi A, Lo Vullo S, Fiore M, Mussi C, Stacchiotti S, Collini P, Lozza L, Pennacchioli E, Mariani L, Casali PG. (2009). Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol, 27 (1), 24-30. doi:10.1200/JCO.2008.17.8871; Lewis JJ, Benedetti F. (1997). Adjuvant therapy for soft tissue sarcomas. Surg Oncol Clin N Am, 6 (4), 847-862.; Pisters PW. (2009). Resection of some - but not all - clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol, 27 (1), 6-8. doi:10.1200/JC0.2008.18.7138; https://www.actabiomedica.ru/jour/article/view/558

  9. 9
  10. 10
    Academic Journal

    Πηγή: Clinical anatomy and operative surgery; Том 11, № 4 (2012); 90-96
    Клиническая анатомия и оперативная хирургия; Том 11, № 4 (2012); 90-96
    Клінічна анатомія та оперативна хірургія; Том 11, № 4 (2012); 90-96

    Περιγραφή αρχείου: application/pdf

  11. 11
  12. 12
    Academic Journal

    Πηγή: Siberian journal of oncology; № 5 (2014); 54-59 ; Сибирский онкологический журнал; № 5 (2014); 54-59 ; 2312-3168 ; 1814-4861 ; undefined

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.siboncoj.ru/jour/article/view/274/276; Angioli R., Palaia I., Zullo M.A., Muzii L., Manci N., Calcagno M., Panici P.B. Diagnostic open laparoscopy in the management of advanced ovarian cancer // Gynecol. Oncol. 2006. Vol. 100. P. 455–461.; Bristow R.E., Chi D.S. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a metaanalysis // Gynecol. Oncol. 2006. Vol. 103. P. 1070–1076.; Cannistra S.A., Matulonis U.A., Penson R.T., Hambleton J., Dupont J., Mackey H., Douglas J., Burger R.A., Armstrong D., Wenham R., McGuire W. Phase II study of bevacizumab in patients with platinumresistant ovarian cancer or peritoneal serous cancer // J. Clin. Oncol. 2007. Vol. 25. P. 5180–5186.; Chan J.K., Urban R., Hu J.M., Shin J.Y., Husain A., Teng N.N., Berek J.S., Osann K., Kapp D.S. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13 918 patients // Br. J. Cancer. 2007. Vol. 96. P. 1817–1822.; Chi D.S., Abu-Rustum N.R., Sonoda Y., Awtrey C., Hummer A., Venkatraman E.S., Franklin C.C., Hamilton F., Gemignani M.L., Barakat R.R. Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy // Am. J. Obstet. Gynecol. 2004. Vol. 191. P. 1138–1145.; Chi D.S., Eisenhauer E.L., Lang J., Huh J., Haddad L., Abu-Rustum N.R., Sonoda Y., Levine D.A., Hensley M., Barakat R.R. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? // Gynecol. Oncol. 2006. Vol. 103. P. 559–564.; Colombo N., Peiretti M., Parma G., Lapresa M., Mancari R., Carinelli S., Sessa C., Castiglione M. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Ann. Oncol. 2010. Vol. 21. Suppl. 5. P. 23–30. doi:10.1093/annonc/mdq244.; Di Giorgio A., Cardi M., Biacchi D., Sibio S., Accarpio F., Ciardi A., Cornali T., Framarino M., Sammartino P. Depth of colorectal-wall invasion and lymph-node involvement as major outcome factors influencing surgical strategy in patients with advanced and recurrent ovarian cancer with diffuse peritoneal metastases // World J. Surg. Oncol. 2013. Vol. 11. P. 64–72. doi:10.1186/1477-7819-11-64.; du Bois A., Reuss A., Harter P., Pujade-Lauraine E., Ray-Coquard I., Pfisterer J. Potential Role of Lymphadenectomy in Advanced Ovarian Cancer: A Combined Exploratory Analysis of Three Prospectively Randomized Phase III Multicenter Trials // J. Clin. Oncol. 2010. Vol. 28. P. 1733–1739. doi:10.1200/JCO.2009.25.3617.; du Bois A., Reuss A., Pujade-Lauraine E., Harter P., Ray-Coquard I., Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGOOVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO) // Cancer. 2009. Vol. 115. P. 1234–1244. doi:10.1002/cncr.24149.; Eisenkop S.M., Friedman R.L., Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study // Gynecol. Oncol. 1998. Vol. 69. P. 103–108.; Fagotti A., Fanfani F., Ludovisi M., Lo Voi R., Bifulco G., Testa A.C., Scambia G. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study // Gynecol. Oncol. 2005. Vol. 96. P. 729–735.; Gagliardi M.L., Polito S., Fagotti A., Fanfani F., Scambia G. Narrow-Band Imaging for Recurrent Ovarian Cancer // J. Minimally Invasive Gynecol. 2013. Vol. 20. Issue 1. P. 10–12. doi:10.1016/j. jmig.2012.01.016.; Glehen O., Mohamed F., Gilly F.N. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia // Lancet Oncol. 2004. Vol. 5. P. 219–228.; Griffith C.T. Surgical resections of tumour bulk in the primary treatment of ovarian carcinoma // National Cancer Institute Monograph. 1975. Vol. 42. P. 101–104.; Harter P., Gnauert K., Hils R., Lehmann T.G., Fisseler-Eckhoff A., Traut A., du Bois A. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer // Int. J. Gynecol. Cancer. 2007. Vol. 17. P. 1238–1244.; Houvenaeghel G., Gutowski M., Buttarelli M., Cuisenier J., Narducci F., Dalle C., Ferron G., Morice P., Meeus P., Stockle E., Bannier M., Lambaudie E., Rouanet P., Fraisse J., Leblanc E., Dauplat J., Querleu D., Martel P., Castaigne D. Modified Posterior Pelvic Exenteration for Ovarian Cancer // Int. J. Gynecol. Cancer. 2009. Vol. 19. Issue 5. P. 968–973. doi:10.1111/IGC.0b013e3181a7f38b.; Leblanc E., Querleu D., Narducci F., Occelli B., Papageorgiou T., Sonoda Y. Laparoscopic staging of early stage invasive adnexal tumors: a 10-year experience // Gynecol. Oncol. 2004. Vol. 94. P. 624–629.; Mandato V.D., Abrate M., De Iaco P., Pirillo D., Ciarlini G., Leoni M., Comerci G., Ventura A., Lenzi B., Amadori A., Rosati F., Martinello R., De Palma R., Ventura C., Belotti L.M., Formisano D., La Sala G.B. Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management // J. Ovarian Res. 2013. Vol. 6. P. 19–26. doi:10.1186/1757-2215-6-19.; Marszalek A., Alran S., Scholl S., Fourchotte V., Plancher C., Rosty C., Meyniel J.P., De Margerie V., Dorval T., De La Rochefordière A., Cottu P., Petrow P., Sastre-Garrau X., Salmon R.J. Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute // Int. J. Surg. Oncol. 2010; 2010: 214919. doi:10.1155/2010/214919.; Meigs J.V. Tumors of the Female Pelvic Organs. New York: MacMillan, 1934. P. 262–263.; Muñoz-Casares F.C., Rufián S., Arjona-Sánchez A., Rubio M.J., Díaz R., Casado Á., Naranjo Á., Díaz-Iglesias C.J., Ortega R., MuñozVillanueva M.C., Muntané J., Aranda E. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study // Cancer Chemother. Pharmacol. 2011. Vol. 68. P. 267–274. doi:10.1007/s00280-011-1646-4.; Nezhat F.R., Pejovic T., Finger T.N., Khalil S.S. Role of Minimally Invasive Surgery in Ovarian Cancer // J. Minimally Invasive Gynecol. 2013. Vol. 20. P. 754–765. doi:10.1016/j.jmig.2013.04.027.; Onda T., Yoshikawa H. Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions // Expert Rev. Anticancer Ther. 2011. Vol. 11. P. 1053–1067. doi:10.1586/era.11.24. Review.; Panici P.B., Maggioni A., Hacker N., Landoni F., Ackermann S., Campagnutta E., Tamussino K., Winter R., Pellegrino A., Greggi S., Angioli R., Manci N., Scambia G., Dell’Anna T., Fossati R., Floriani I., Rossi R.S., Grassi R., Favalli G., Raspagliesi F., Giannarelli D., Martella L., Mangioni C. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial // J. Natl. Cancer Inst. 2005. Vol. 97. P. 560–566.; Rauh-Hain J.A., Rodriguez N., Growdon W.B., Goodman A.K., Boruta D.M. 2nd, Horowitz N.S., del Carmen M.G., Schorge J.O. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer // Ann. Surg. Oncol. 2012. Vol. 19 (3). P. 959–965. doi:10.1245/ s10434-011-2100-x.; Rutten M.J., Gaarenstroom K.N., Van Gorp T., van Meurs H.S., Arts H.J., Bossuyt P.M., Ter Brugge H.G., Hermans R.H., Opmeer B.C., Pijnenborg J.M., Schreuder H.W., Schutter E.M., Spijkerboer A.M., Wensveen C.W., Zusterzeel P., Mol B.W., Kenter G.G., Buist M.R. Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study // BMC Cancer. 2012. Vol. 12. P. 31. doi:10.1186/1471-2407-12-31.; Sugarbaker P.H., Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy // Ann. Surg. Oncol. 1999. Vol. 6. P. 727–731.; Valle M., Van Der Speeten K., Garofalo A. Laparoscopic Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) in the Management of Refractory Malignant Ascites: A Multi-Institutional Retrospective Analysis in 52 Patients // J. Surg. Oncol. 2009. Vol. 100. P. 331–334. doi:10.1002/jso.21321.; Vergote I., Tropé C.G., Amant F., Kristensen G.B., Ehlen T., Johnson N., Verheijen R.H., van der Burg M.E., Lacave A.J., Panici P.B., Kenter G.G., Casado A., Mendiola C., Coens C., Verleye L., Stuart G.C., Pecorelli S., Reed N.S. Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer // N. Engl. J. Med. 2010. Vol. 363. P. 943–953. doi:10.1056/NEJMoa0908806.; Whitney C.W., Spirtos N. Gynecologic Oncology Group Surgical Procedures Manual. 2010 January: [Электронный документ] (https:// gogmember.org/manuals/pdf/surgman.pdf).; Wimberger P., Lehmann N., Kimmig R., Burges A., Meier W., Du Bois A. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR) // Gynecol. Oncol. 2007. Vol. 106. P. 69–74.; Winter W.E., Maxwell G.L., Tian C., Sundborg M.J., Rose G.S., Rose P.G., Rubin S.C., Muggia F., McGuire W.P. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study // J. Clin. Oncol. 2007. Vol. 25. P. 3621–3627.; Winter W.E., Maxwell G.L., Tian C., Sundborg M.J., Rose G.S., Rose P.G., Rubin S.C., Muggia F., McGuire W.P. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study // J. Clin. Oncol. 2008. Vol. 26. P. 83–89.; https://www.siboncoj.ru/jour/article/view/274; undefined

    Διαθεσιμότητα: https://www.siboncoj.ru/jour/article/view/274

  13. 13
    Academic Journal

    Πηγή: Surgery and Oncology; Том 6, № 1 (2016); 22-26 ; Хирургия и онкология; Том 6, № 1 (2016); 22-26 ; 2949-5857 ; 10.17650/2220-3478-2016-6-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.onco-surgery.info/jour/article/view/162/137; Бердов Б.А., Невольских A.A., Ерыгин Д.В., Титова Л.Н. Лечение местнораспространенного рака прямой кишки. Вопросы онкологии 2007;53(5):578–83. [Berdov B.А., Nevol’skikh A.A., Еrygin D.V., Тitovа L.N. Treatment of the locally spread colon cancer. Voprosy onkologii = Oncology Issues 2007;53(5):578–83. (In Russ.)].; Тулина И.А., Царьков П.В., Комкова Н.Е. Оценка безопасности комбинированных вмешательств при местно-распространенном раке прямой кишки в зависимости от преимущественного направления опухолевого роста. Вестник хирургической гастроэнтерологии 2010;(1):11–22. [Тulinа I.А., Tsar’kov P.V., Komkovа N.Е. Evaluation of the safety of combined interferences at the locally spread colon cancer depending on the preferred tumor direction. Vestnik khirurgicheskoy gastroenterologii = Herald of Surgical Gastroenterology 2010;(1):11–22. (In Russ.)].; Барсуков Ю.А. Комбинированное и комплексное лечение больных раком прямой кишки. Рекомендации к лечению. М., 2011. [Barsukov Yu.А. Combined and comprehensive treatment of patients with colon cancer. Treatment recommendations. Мoscow, 2011. (In Russ.)].; Царьков П.В., Тулина И.А., Федоров Д.Н. и др. Отдаленные результаты хирургического лечения местно-распространенного рака прямой кишки с использованием экстрафасциального принципа выделения. Российский журнал гастроэнтерологии, гепатологии, колопроктологии 2010;20(4):75–82. [Tsar’kov P.V., Тulinа I.А., Fedorov D.N. et al. Afterhistory of the surgical treatment of the locally spread colon cancer with use of the extrafascial apportionment principle. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology 2010;20(4):75–82. (In Russ.)].; ХубезовД.А., ПучковК.В., КолесниковаН.О. Эффективность МРТ в дооперационном стадировании рака прямой кишки. Колопроктология 2009;28(2):38–41. [Hubezov D.А., Puchkov K.V., Kolesnikovа N.О. MRT efficiency in the pre-operation staging of the colon cancer. Koloproktologiya = Coloproctology 2009;28(2):38–41. (In Russ.)].; Caricato M., Borzomati D., Ausania F. et al. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 2006;32(2):126–32.; Hilditch J.R., Lewis J., Peter A. et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24(3):161–75.; Chen S.L., Steele S.R., Eberhardt J. et al. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer. Ann Surg 2011;253(1):82–7.

  14. 14
  15. 15
  16. 16
    Academic Journal

    Πηγή: Surgery and Oncology; Том 5, № 2 (2015); 41-44 ; Хирургия и онкология; Том 5, № 2 (2015); 41-44 ; 2949-5857 ; 10.17650/2220-3478-2015-5-2

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.onco-surgery.info/jour/article/view/134/116; Melton G.B., Paty P.B., Boland P.J. et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006;49(8):1099–107.; Akasu T., Yamaguchi T., Fujimoto Y. et al. Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma: analyses of prognostic factors and recurrence patterns. Ann Surg Oncol 2007;14(1):74–83.; Bhangu A., Brown G., Akmal M., Tekkis P. Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer. Br J Surg 2012;99(10):1453–61.; Bosman S.J., Vermeer T.A., Dudink R.L. et al. Abdominosacral resection: Long–term outcome in 86 patients with locally advanced or locally recurrent rectal cancer. Eur J Surg Oncol 2014;40(6):699–705.; Ferenschild F.T., Vermaas M., Verhoef C. et al. Abdominosacral resection for locally advanced and recurrent rectal cancer. Br J Surg 2009;96(11):1341–7.; Mannaerts G.H., Rutten H.J., Martijn H. et al. Abdominosacral resection for primary irresectable and locally recurrent rectal cancer. Dis Colon Rectum 2001;44(6):806–14.; Kusters M., Holman F.A., Martijn H. et al. Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment. Radiother Oncol 2009;92(2): 221–5.; Mirnezami R., Chang G.J., Das P. et al. Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications. Surg Oncol 2013;22(1):22–35.; Wanebo H.J., Marcove R.C. Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg 1981;194(4):458–71.; Kido A., Koyama F., Akahane M. et al. Extent and contraindications for sacral amputation in patients with recurrent rectal cancer: a systematic literature review. J Orthop Sci 2011;16(3):286–90.; Dozois E.J., Privitera A., Holubar S.D. et al. High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved? J Surg Oncol 2011;103(2):105–9.; Bebenek M., Pudełko M., Cisarz K. et al. Therapeutic results in low–rectal cancer patients treated with abdominosacral resection are similar to those obtained by means of anterior resection in midand upper-rectal cancer cases. Eur J Surg Oncol 2007;33(3):320–3.; Wanebo H.J., Antoniuk P., Koness R.J. et al. T Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 1999;42(11):1438–48.; Martijnse I.S., Holman F., Nieuwenhuijzen G.A. et al. Perineal hernia repair after abdominoperineal rectal excision. Dis Colon Rectum 2012;55(1):90–5.; Milne T., Solomon M.J., Lee P. et al. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Dis Colon Rectum 2014;57(10):1153–61.

  17. 17
    Academic Journal

    Πηγή: Surgery and Oncology; № 4 (2013); 57-62 ; Хирургия и онкология; № 4 (2013); 57-62 ; 2949-5857 ; 10.17650/2220-3478-2013-0-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.onco-surgery.info/jour/article/view/100/94; Cancer Fact Sheet. Colorectal Cancer Incidence and Mortality Worldwide in 2008 [Electronic resource] / GLOBOCAN (IARC). Lyon, 2008. http://globocan.iarc.fr/factsheets/cancers/colorectal.asp. Date of access: 03.03.2013.; Мерабишвили В.М. Выживаемость онкологических больных. Под ред. проф. Ю.А. Щербука. СПб., 2011. 408 с.; Gebhardt C., Meyer W., Ruckriegel S., Meier U. Multivisceral resection of advanced colorectal carcinoma. Langenbecks Arch Surg 1999;2(384):194–9.; Park S., Lee Y.S. Analysis of the prognostic effectiveness of a multivisceral resection for locally advanced colorectal cancer. J Korean Soc Coloproctol 2011;1(27):21–6.; Staniunas R.J., Schoetz D.J. Jr. Extended resection for carcinoma of colon and rectum. Surg Clin North Am 1993;1(73):117–29.; Lehnert T., Methner M., Pollok A. et al. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann of Surg 2002;235(2):217–25.; Nelson H., Petrelli N., Carlin A. et al. Guidelines 2000 for colon and rectal surgery. J Natl Cancer Inst 2001;93:583–96.; Otchy D., Hyman N.H., Simmang C. et al. Practice parameters for colon cancer. Dis Colon Rectum 2004;47:1269–84.; Tjandra J.J., Kikenny J.W., Buie W.D. et al. Practice parameters for the management of rectal cancer. Dis Colon Rectum 2005;48:411–23.; Hoffmann M., Phillips C., Oevermann E. et al. Multivisceral and standard resections in colorectal cancer. Langenbecks Arch Surg 2012;397(1):75–84.; Croner R.S., Merkel S., Papadopoulos T. et al. Multivisceral resection for colon carcinoma. Dis Colon Rectum 2009;52(8):1381–6.; Eisenberg S.B., Kraybill W.G., Lopez M.J. Long-term results of surgical resection of locally advanced colorectal carcinoma. Surgery 1990;108(4):779–85.; Nakafusa Y., Tanaka T., Tanaka M. et al. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum 2004;47(12):2055–63.

  18. 18
    Academic Journal

    Πηγή: Head and Neck Tumors (HNT); № 4 (2014); 4-7 ; Опухоли головы и шеи; № 4 (2014); 4-7 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2014-0-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://ogsh.abvpress.ru/jour/article/view/102/116; Бржезовский В. Ж., Любаев В. Л., Субраманиан С. Факторы прогноза и хирургическое лечение дифференцированного рака щитовидной железы. Вестник РОНЦ им. Блохина РАМН 2009;20 (прил.):8–9. [Brzhezovskiy V. Z., Lyubayev V. L., Subramanian S. Factors of forecasting and surgical treatment of differentiated thryroid gland cancer. Herald of N. N. Blokhin Russian Cancer Research Center with Russian Academy of Medical Sciences 2009;20 (appl.): 8–9 (In Russ.)].; Петерсон Б. Е. Хирургическое лечение злокачественных опухолей. М.: Медицина, 1976. С. 24. [Peterson B. E. Surgical treatment of malignant tumors. Moscow: Medizina, 1976. P. 24 (In Russ.)].; Романчишен А. Ф. Хирургия щитовидной и околощитовидной желез. СПб.: ИПК «Вести», 2009. С. 75–76. [Romanchishen A. F. Surgery of thyroid and parathyroid glands. St. Petersburg: IPC Vesti, 2009. Pp. 75–76 (In Russ.)].; Brauckhoff M., Dralle H. Extrathyroidal thyroid cancer: results of tracheal shaving and tracheal resection. Chirurg 2011;82(2): 134–40.; Fujimoto Y., Obara T., Ito Y. et al. Aggressive surgical approach for locally invasive papillary carcinoma of the thyroid in patients over forty-five years of age. Surgery 1986 Dec;100(6):1098–107.; Grillo H. C., Suen H. C., Mathisen D. J., Wain J. C. Resectional management of thyroid carcinoma invading the airway. Ann Thorac Surg 1992;54(1):3–9.; Grillo H. C., Zannini P. Resectional management of airway invasion by thyroid carcinoma. Ann Thorac Surg 1986;42(3): 87–98.; Brauckhoff M., Dralle H. Cervicovisceral resection in invasive thyroid tumors. Chirurg 2009;80(2):88–98.; Shah J., Patel S. G., Singh B. Head and neck surgery and oncology. Fourth edition. Elsevier, 2012. 838 p.; Honings J., Stephen A. E., Marres H. A., Gaissert H. A. The management of thyroid carcinoma invading the larynx or trachea. Laryngoscope 2010;120 (4):682–9.; Давыдов М. И., Матякин Е. Г., Попкова Л. П. и др. Комплексная лучевая диагностика и хирургическое лечение местно-распространенного рака щитовидной железы. Материалы межрегиональной конференции с международным участием «Рак щитовидной железы и эндемический зоб». Екатеринбург, 2007. С. 121–122. [Davydov M. I., Matyakin E. G., Popkova L. P. et al. Complex radiation diagnosis and surgical treatment of locally distributed thyroid cancer. Materials of Inter-Regional Conference with International Participation «Thyroid Gland Cancer and Hypothyroidism». Ekaterinburg, 2007. Pp. 121–122 (In Russ.)].; https://ogsh.abvpress.ru/jour/article/view/102

  19. 19
    Academic Journal

    Πηγή: Malignant tumours; № 2 (2013); 107-113 ; Злокачественные опухоли; № 2 (2013); 107-113 ; 2587-6813 ; 2224-5057

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.malignanttumors.org/jour/article/view/41/45; Чиссов В. И., Старинский В. В., Петрова Г. В. Состояние онкологической помощи населению России в 2010 году. М.: ФГУ «МНИОИ им. П. А. Герцена» Минздравсоцразвития России, 2011. — С. 68-75.; Akiyoshi T, Fujimoto Y, Konishi T, Kuroyanagi H, Ueno M, Oya M, Miyata S; Yamaguchi T. Prognostic factors for survival after salvage surgery for locoregional recurrence of colon cancer. Am J Surg. 2011 Jun; 201 (6): 726-33.; Bowne WB, Lee B, Wong WD, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum 2005; 48: 897-909.; Carne PW, Frye JN, Kennedy-Smith A, et al. Local invasion of the bladder with colorectal cancers: surgical management and patterns of local recurrence. Dis Colon Rectum 2004; 47: 44-47.; Croner RS, Merkel S, Papadopoulos T, et al. Multivisceral resection for colon carcinoma. Dis Colon Rectum. 2009 Aug; 52 (8): 1381-6.; Downing A, Aravani A, Macleod U, Oliver S, Finan PJ, Thomas JD, Quirke P, Wilkinson JR, Morris EJ. Early mortality from colorectal cancer in England: a retrospective observational study of the factors associated with death in the first year after diagnosis. Br J Cancer. 2013 Feb 19; 108 (3): 681-5.; Elferink MA, Visser O, Wiggers T, et al. Prognostic factors for locoregional recurrences in colon cancer. Ann Surg Oncol. 2012 Jul; 19 (7): 2203-11.; Harris G. J., Church J. M., et al. Factors affecting local recurrence of colonic adenocarcinoma. // Dis. Colon Rectum. 2002. 45 (8): 1029-34.; Hida J, Yasutomi M, Shindoh K, et al. Second-look operation for recurrent colorectal cancer based on carcino-embryonic antigen and imaging techniques. Dis Colon Rectum 1996; 39: 74-79.; Jemal A., Murray T., Warel B, et al. Cancer Statistic 2005. CA Cancer J Clin. 2005; 55: 10-30.; Koea JB, Lanouette N, Paty PB, et al. Abdominal wall recurrence after colorectal resection for cancer. Dis Colon Rectum 2000; 43: 628-632.; Meropol NJ, Berger NA. Colon cancer recurrence: insights from the interface between epidemiology, laboratory science, and clinical medicine. J Natl Cancer Inst. 2012 Nov 21; 104 (22): 1697-8.; Platell C, Ng S, et al. Changing management and survival in patients with stage IV colorectal cancer. Dis Colon Rectum. 2011, 54: 214-9.; Taylor WE, Donohue JH, Gunderson LL, et al. The Mayo clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann Surg Oncol 2002; 9: 177-185.; Yamamoto Y, Imai H, Iwamoto S, et al. Surgical treatment of the recurrence of colorectal cancer. Jpn J Surg 1996; 26: 164-168.; https://www.malignanttumors.org/jour/article/view/41

  20. 20